PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is c...Show More
competitor of
Metrics
marketSTOCKS
msh_idCOM:PAINREFORM
localeus
websitehttps://painreform.com/
ipo_date2020-09-01
primary_stock_msh_idNASDAQ:PRFX
source_ref09dfb5da-b756-4836-b4ea-24b04f15c9a0
products_or_servicesPRF-110, a viscous oil-based solution for post-operative analgesia, and a proprietary extended-release drug-delivery system.
Israel